Literature DB >> 9772140

Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (kinako).

S Watanabe1, M Yamaguchi, T Sobue, T Takahashi, T Miura, Y Arai, W Mazur, K Wähälä, H Adlercreutz.   

Abstract

To take advantage of the various pharmacologic activities of soy bean isoflavones, more detailed studies of the absorption and excretion rates of these compounds in humans and subsequent evaluation of their bioavailabilities are required. We conducted a pharmacokinetic study of soybean isoflavones in seven healthy male volunteers. After ingestion of 60 g of kinako (baked soybean powder, containing 103 micromol daidzein and 112 micromol genistein), changes of the isoflavone and metabolite concentrations in plasma, urine and feces were measured by gas chromatography-mass spectrometry. The plasma concentration of genistein increased after 2 h and reached its highest value of 2.44 +/- 0.65 micromol/L 6 h later. The plasma concentration of daidzein peaked at 1.56 +/- 0.34 micromol/L at the same time, but it was always lower than that of genistein. Peak plasma concentration of O-desmethylangolensin (O-DMA) and equol appeared after the daidzein peak in four and two subjects, respectively. In contrast with plasma, daidzein was the main component in urine. Urinary daidzein excretion started to increase shortly after the rise in its plasma concentration and reached 2.4 micromol/h 8 h after ingestion of kinako. Genistein excretion in urine paralleled that of daidzein, but the value at 6 h was about half (1.1 micromol/h). The majority of ingested isoflavones after ingestion of kinako were recovered on d 2 or 3 in the feces. Total recovery of daidzein, O-DMA and equol from urine and feces was 54.7%, calculated from daidzein intake; 20.1% of administered genistein was recovered as genistein. The half-lives of plasma genistein and daidzein were 8.36 and 5.79 h, respectively. The individual plasma and urinary concentrations of equol and O-DMA were quite variable; subjects were classified as high and low metabolizers. The high plasma concentration of isoflavones for at least several hours after a single ingestion of soy protein suggests that these compounds may interact with macromolecules and have biological effects.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9772140     DOI: 10.1093/jn/128.10.1710

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  56 in total

Review 1.  Equol: history, chemistry, and formation.

Authors:  Kenneth D R Setchell; Carlo Clerici
Journal:  J Nutr       Date:  2010-06-02       Impact factor: 4.798

2.  Isoflavone pharmacokinetics and metabolism after consumption of a standardized soy and soy-almond bread in men with asymptomatic prostate cancer.

Authors:  Jennifer H Ahn-Jarvis; Steven K Clinton; Elizabeth M Grainger; Kenneth M Riedl; Steven J Schwartz; Mei-Ling T Lee; Raul Cruz-Cano; Gregory S Young; Gregory B Lesinski; Yael Vodovotz
Journal:  Cancer Prev Res (Phila)       Date:  2015-08-14

3.  The estrogenic effect of Pueraria mirifica on gonadotrophin levels in aged monkeys.

Authors:  Hataitip Trisomboon; Suchinda Malaivijitnond; Gen Watanabe; Wichai Cherdshewasart; Kazuyoshi Taya
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

4.  Effects of fermented soy milk on the liver lipids under oxidative stress.

Authors:  Ching-Yi Lin; Zheng-Yu Tsai; I-Chi Cheng; Shyh-Hsiang Lin
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

5.  Daidzein and genistein have differential effects in decreasing whole body bone mineral density but had no effect on hip and spine density in premenopausal women: A 2-year randomized, double-blind, placebo-controlled study.

Authors:  Fatima Nayeem; Nai-Wei Chen; Manubai Nagamani; Karl E Anderson; Lee-Jane W Lu
Journal:  Nutr Res       Date:  2019-07-03       Impact factor: 3.315

6.  Genistein administered as a once-daily oral supplement had no beneficial effect on the tibia in rat models for postmenopausal bone loss.

Authors:  Russell T Turner; Urszula T Iwaniec; Juan E Andrade; Adam J Branscum; Steven L Neese; Dawn A Olson; Lindsay Wagner; Victor C Wang; Susan L Schantz; William G Helferich
Journal:  Menopause       Date:  2013-06       Impact factor: 2.953

7.  Synergistic effect of genistein and BCNU on growth inhibition and cytotoxicity of glioblastoma cells.

Authors:  Sami Khoshyomn; David Nathan; Gregory C Manske; Turner M Osler; Paul L Penar
Journal:  J Neurooncol       Date:  2002-05       Impact factor: 4.130

8.  Isoflavones in urine, saliva, and blood of infants: data from a pilot study on the estrogenic activity of soy formula.

Authors:  Yang Cao; Antonia M Calafat; Daniel R Doerge; David M Umbach; Judy C Bernbaum; Nathan C Twaddle; Xiaoyun Ye; Walter J Rogan
Journal:  J Expo Sci Environ Epidemiol       Date:  2008-07-30       Impact factor: 5.563

9.  Prostatic soy isoflavone concentrations exceed serum levels after dietary supplementation.

Authors:  Christopher D Gardner; Beibei Oelrich; Jenny P Liu; David Feldman; Adrian A Franke; James D Brooks
Journal:  Prostate       Date:  2009-05-15       Impact factor: 4.104

10.  The effects of dietary treatment with S-equol on learning and memory processes in middle-aged ovariectomized rats.

Authors:  Steven L Neese; Samantha L Pisani; Daniel R Doerge; William G Helferich; Estatira Sepehr; Amar G Chittiboyina; Sateesh Chandra Kumar Rotte; Troy J Smillie; Ikhlas A Khan; Donna L Korol; Susan L Schantz
Journal:  Neurotoxicol Teratol       Date:  2013-12-22       Impact factor: 3.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.